Venous thromboembolism, which includes deep venous thrombosis and pulmonary
embolism, is a potentially preventable condition in children. In adults, pharmacologic …

Venous thromboembolic (VTE) disease encompasses pulmonary embolism (PE) and deep
vein thrombosis (DVT). PE is believed to be a rare event in children. 1, 2 However, the …

Venous thromboembolism (VTE) is more frequent in infants than in older children. Treatment
guidelines in children are adapted from adult VTE data, but do not currently include direct …

Despite the high rate of central venous catheter (CVC)-related venous thromboembolic
(VTE) complications and long-term sequelae, CVCs remain a vital component of patient care …

Paediatric venous thromboembolism (VTE) is a rare disorder but a rising incidence has
been observed in recent years, due to improved VTE diagnosis and increased use of central …

Venous thromboembolism (VTE) is a leading cause of morbidity and mortality among
hospitalized patients, including children. In recent years, it has become clear that …

The incidence of venous thromboembolism (VTE) in children is increasing. Hospitalized
infants and adolescents are at highest risk, and most individuals who have VTE have …

Background The incidence of pediatric hospital‐associated venous thromboembolism (HA‐
VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE) occurring …

Abstract Objective The American Pediatric Surgical Association Outcomes and Evidence-
Based Practice Committee conducted a systematic review to describe the epidemiology of …

Background/objectives Hospital acquired venous thromboembolism in children is
associated with significant morbidity/mortality. Prevention strategies include sequential …